about
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givasto...
Read More
1.38
-0.07
(-4.83%)
6.6M
XNAS Volume
High volume today
XNAS 25 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
I-Mab (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..